Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a consensus rating of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and eight have given a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $32.8182.

Several equities analysts recently weighed in on ACHC shares. Bank of America downgraded shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and cut their price target for the stock from $27.00 to $25.00 in a report on Wednesday, September 10th. Guggenheim decreased their price objective on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Barclays dropped their price target on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 6th. Mizuho cut their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, August 13th. Finally, Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. Caitong International Asset Management Co. Ltd increased its stake in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after acquiring an additional 1,234 shares during the last quarter. Allworth Financial LP grew its holdings in shares of Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the period. EverSource Wealth Advisors LLC increased its position in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Hantz Financial Services Inc. raised its stake in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares during the period. Finally, Covestor Ltd boosted its holdings in Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after purchasing an additional 812 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $16.02 on Monday. The company has a market cap of $1.48 billion, a PE ratio of 10.61, a P/E/G ratio of 4.56 and a beta of 0.97. Acadia Healthcare has a fifty-two week low of $15.68 and a fifty-two week high of $47.08. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The business has a 50-day simple moving average of $22.72 and a two-hundred day simple moving average of $22.62.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. During the same quarter in the prior year, the business posted $0.91 EPS. Acadia Healthcare’s revenue for the quarter was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, equities analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.